COMMUNIQUÉS West-GlobeNewswire

Kezar Life Sciences to Present at 2018 Wells Fargo Healthcare Conference
29/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
EXTON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
29/08/2018
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in September 2018
29/08/2018
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Diffusion Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
CHARLOTTESVILLE, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on improving patient outcomes in unmet [...]
Bio-Path Holdings to Present at the H.C. Wainwright 20th Annual Global Investment Conference
29/08/2018
HOUSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
29/08/2018
WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Bellerophon Therapeutics to Present at Rodman & Renshaw 20th Annual Global Investment Conference
29/08/2018
WARREN, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, Chief [...]
iCAD Announces AERB Approval of Xoft System in India
29/08/2018
First installation of versatile, multi-platform Xoft System in India demonstrates strong, continued momentum in global commercialization of electronic brachytherapy (eBx) NASHUA, N.H. and HYDERABAD, India, Aug. 29, 2018 [...]
HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies
29/08/2018
TUCSON, Ariz., Aug. 29, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the pre- [...]
resTORbio to Present at Wells Fargo 2018 Healthcare Conference
29/08/2018
BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
29/08/2018
NEW HAVEN, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
BrainStorm Cell Therapeutics to Provide Corporate Update at the H.C. Wainwright & Co 20th Annual Investor Conference
29/08/2018
NEW YORK and PETACH TIKVAH, Israel, Aug. 29, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today [...]
Corium to Present at the H. C. Wainwright 20th Annual Global Investment Conference
29/08/2018
MENLO PARK, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Kiniksa to Present Late-Breaking KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
29/08/2018
HAMILTON, Bermuda, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing [...]
Neos Therapeutics to Present at the Wells Fargo Healthcare Conference
29/08/2018
DALLAS and FORT WORTH, Texas, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative [...]
Conatus Pharmaceuticals to Present at BioCentury NewsMakers Conference
29/08/2018
SAN DIEGO , Aug. 29, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]
Intercept to Present at Upcoming Investor Conferences
29/08/2018
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Aptose to Present at Upcoming Investor Conferences in September 2018
29/08/2018
SAN DIEGO and TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]

Pages